Yu Lun

1.1k citations
58 papers · 830 indexed · h-index 17

Yu Lun

52 papers receiving 817 citations

Peers

Yu Lun
Comparison fields: 5 of 105
  • Endocrinology, Diabetes and Metabolism 219
  • Immunology 151
  • Pulmonary and Respiratory Medicine 201
  • Cancer Research 88
  • Oncology 113
Replace Consuelo González‐Manchón with:
Consuelo González‐Manchón Spain
Katsumi Yabusaki Japan
Elisa Roztocil United States
Hideaki Tanaka Japan
Mette K. Hagensen Denmark
Gabriela Guzmán Spain
Yousef El‐Gohary United States
Chela James United Kingdom
Chenzhong Fu United States
Jun Ding China
Yu Lun relative to Consuelo González‐Manchón Spain Consuelo González‐Manchón's profile →
Citations per field
00.5×6.5×
Consuelo González‐Manchón · 1×
Citations per year

Countries citing papers authored by Yu Lun

Since Specialization
Citations

This map shows the geographic impact of Yu Lun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Lun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Lun more than expected).

Fields of papers citing papers by Yu Lun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Lun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Lun. The network helps show where Yu Lun may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yu Lun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yu Lun Line = papers co-authored together Yu Lun links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20251
3 20250
4 20242
5 20243
6 20240
7 202417
8 20242
9 20231
10 20236
11 20225
12 202226
13 20222
14 202114
15 20217
16 202115
17 20218
18 20217
19 201410
20 201345

About Yu Lun

Yu Lun is a scholar working on Pulmonary and Respiratory Medicine, Immunology, Internal Medicine, Endocrinology, Diabetes and Metabolism and Virology, having authored 58 papers that have together received 830 indexed citations. Recurring topics across this work include Aortic aneurysm repair treatments (10 papers), Aortic Disease and Treatment Approaches (8 papers), Ferroptosis and cancer prognosis (6 papers), Thyroid Cancer Diagnosis and Treatment (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Immune Cell Function and Interaction (4 papers), Atherosclerosis and Cardiovascular Diseases (4 papers) and Cardiac Valve Diseases and Treatments (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (219 citations), Immunology (151 citations), Pulmonary and Respiratory Medicine (201 citations), Cancer Research (88 citations) and Oncology (113 citations). Yu Lun has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Shijie Xin, Jian Zhang, Han Jiang, Zhiquan Duan, Xiaoyu Wu, Yanshuo Han, Shiyue Wang, Song Wu, Jianjian Sun and Yuzhen He. Their work appears in journals such as International Immunopharmacology, Annals of Vascular Surgery, Scientific Reports, Aging and Journal of Vascular Surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026